Matches in Wikidata for { <http://www.wikidata.org/entity/Q84974786> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q84974786 description "article scientifique publié en 2011" @default.
- Q84974786 description "artículu científicu espublizáu en xunetu de 2011" @default.
- Q84974786 description "im Juli 2011 veröffentlicher wissenschaftlicher Artikel" @default.
- Q84974786 description "scientific article published on 15 July 2011" @default.
- Q84974786 description "wetenschappelijk artikel" @default.
- Q84974786 description "наукова стаття, опублікована в липні 2011" @default.
- Q84974786 name "Survival benefit with the combination of docetaxel, gemcitabine and erlotinib in advanced and/or metastatic pancreatic cancer patients" @default.
- Q84974786 name "Survival benefit with the combination of docetaxel, gemcitabine and erlotinib in advanced and/or metastatic pancreatic cancer patients" @default.
- Q84974786 type Item @default.
- Q84974786 label "Survival benefit with the combination of docetaxel, gemcitabine and erlotinib in advanced and/or metastatic pancreatic cancer patients" @default.
- Q84974786 label "Survival benefit with the combination of docetaxel, gemcitabine and erlotinib in advanced and/or metastatic pancreatic cancer patients" @default.
- Q84974786 prefLabel "Survival benefit with the combination of docetaxel, gemcitabine and erlotinib in advanced and/or metastatic pancreatic cancer patients" @default.
- Q84974786 prefLabel "Survival benefit with the combination of docetaxel, gemcitabine and erlotinib in advanced and/or metastatic pancreatic cancer patients" @default.
- Q84974786 P1433 Q84974786-2D502A22-B6E7-4DFF-9B44-1E0E44B6F779 @default.
- Q84974786 P1476 Q84974786-35E18ACC-05DD-4BC8-9E93-D1C27A7A3B4A @default.
- Q84974786 P2093 Q84974786-0FA561EF-1846-4B3A-BD8C-F023F73EE778 @default.
- Q84974786 P2093 Q84974786-4FE244A3-D65F-466F-B707-3D3F49B2C0A7 @default.
- Q84974786 P2093 Q84974786-5AEA93B7-5F35-4BC3-9B42-260C347C9FEA @default.
- Q84974786 P2093 Q84974786-BA82601C-DD31-465C-8850-933ECD50E785 @default.
- Q84974786 P2093 Q84974786-BBDDCD81-F94E-4077-A7FC-C8A60361BECB @default.
- Q84974786 P304 Q84974786-D4F0EB7F-036B-4FD3-98B2-1F323D059A5E @default.
- Q84974786 P31 Q84974786-718632C1-15A7-4533-B1FE-075E6C57EBFA @default.
- Q84974786 P356 Q84974786-CA6DE236-4471-48CD-9C1F-F55472DC7150 @default.
- Q84974786 P433 Q84974786-DB0986EC-E8DA-4A5F-87DA-FEE8CF14A3E9 @default.
- Q84974786 P478 Q84974786-1F6CA2C5-33DE-4452-B30A-9451ECF35E85 @default.
- Q84974786 P577 Q84974786-535F938A-8982-4F83-AA50-6219A1C7ABF3 @default.
- Q84974786 P698 Q84974786-2E175D8C-26B8-4320-824D-1EE358A74EB0 @default.
- Q84974786 P921 Q84974786-063ADD7A-7B44-4EA9-9C5B-E114E2282E81 @default.
- Q84974786 P921 Q84974786-CDBE63C7-9A9F-4CAE-8CEC-653BB6624301 @default.
- Q84974786 P356 HGE10455 @default.
- Q84974786 P698 21940348 @default.
- Q84974786 P1433 Q15752074 @default.
- Q84974786 P1476 "Survival benefit with the combination of docetaxel, gemcitabine and erlotinib in advanced and/or metastatic pancreatic cancer patients" @default.
- Q84974786 P2093 "Andriani Tsiakou" @default.
- Q84974786 P2093 "Georgios F Samelis" @default.
- Q84974786 P2093 "Konstantinos Ekmektzoglou" @default.
- Q84974786 P2093 "Manoussos Konstadoulakis" @default.
- Q84974786 P2093 "Styliani Giannakaki" @default.
- Q84974786 P304 "1776-1781" @default.
- Q84974786 P31 Q13442814 @default.
- Q84974786 P356 "10.5754/HGE10455" @default.
- Q84974786 P433 "110-111" @default.
- Q84974786 P478 "58" @default.
- Q84974786 P577 "2011-07-15T00:00:00Z" @default.
- Q84974786 P698 "21940348" @default.
- Q84974786 P921 Q212961 @default.
- Q84974786 P921 Q420436 @default.